Riskpilot← Back to searchSign inGet full accessELDON BIOLOGICALS A/S
A/SActiveCVR 26747007Sandtoften 10Manufacture of other chemical products n.e.c. · NACE 2059Est. 200217 employees
Revenue 2025
DKK 13,6M
-8% vs 2024
EBITDA margin
34.4%
-37% vs 2024
Equity ratio
87.8%
Financial strength
Net profit 2025
DKK 3,9M
-42% vs 2024
| Revenue | DKK 13,6M | -8% |
| EBITDA | DKK 4,7M | -37% |
| Net profit | DKK 3,9M | -42% |
| Total assets | DKK 47,9M | +2% |
| Equity | DKK 42,1M | +5% |
| Employees | 17 | — |
Legal name
ELDON BIOLOGICALS A/S
CVR number
26747007
Legal form
Aktieselskab
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
10. august 2002
Share capital
DKK 500.000
Employees
17 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren og et medlem af bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er udvikling, fremstilling og salg af produkter og tjenesteydelser til sundhedssektoren, herunder investering og hermed beslægtet virksomhed i sundhedssektoren og andre relevante sektorer.
Address
Sandtoften 10
Phone
+4545931111
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.907 | 4.092 | 4.901 | 6.061 | 6.074 | 7.983 | 9.520 | 9.537 | 14.331 | 19.531 | 16.383 | 12.307 | 14.865 | 13.635 |
| Staff expenses | -2.282 | -3.014 | -3.162 | -3.746 | -4.220 | -4.476 | -4.404 | -5.171 | -6.258 | -8.032 | -6.163 | -5.556 | -7.407 | -8.942 |
| EBITDA | 1.625 | 1.079 | 1.740 | 2.316 | 1.854 | 3.507 | 5.117 | 4.366 | 8.073 | 11.499 | 10.219 | 6.752 | 7.442 | 4.693 |
| Depreciation & amort. | -212 | 368 | -210 | -201 | -185 | -170 | -143 | -164 | -407 | -404 | -391 | -405 | -353 | -72 |
| EBIT | 1.413 | 711 | 1.529 | 2.115 | 1.669 | 3.336 | 4.974 | 4.202 | 7.666 | 11.095 | 9.828 | 6.346 | 7.090 | 4.621 |
| Net financials | -226 | -223 | -179 | -30 | -91 | -101 | -157 | 52 | 810 | 474 | -3.640 | 507 | 1.413 | 402 |
| Profit before tax | 1.186 | 488 | 1.350 | 2.085 | 1.578 | 3.236 | 4.816 | 4.254 | 8.476 | 11.569 | 6.188 | 6.853 | 8.503 | 5.024 |
| Tax | -0 | -461 | 283 | 583 | 359 | 620 | 1.062 | 944 | 1.868 | 2.471 | 1.216 | 1.491 | 1.829 | 1.123 |
| Net profit | 1.186 | 949 | 1.067 | 1.502 | 1.219 | 2.616 | 3.755 | 3.310 | 6.609 | 9.098 | 4.972 | 5.363 | 6.674 | 3.900 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.725 | 4.041 | 4.899 | 6.455 | 6.407 | 9.466 | 12.370 | 15.245 | 21.972 | 32.347 | 35.482 | 39.588 | 46.713 | 47.875 |
| Equity | -3.199 | -2.250 | -1.183 | 319 | 1.272 | 3.887 | 7.142 | 10.452 | 16.549 | 25.147 | 29.619 | 34.482 | 40.156 | 42.056 |
| Long-term debt | 5.280 | 4.624 | 3.300 | 3.300 | 3.300 | 3.300 | 0 | 0 | 0 | 0 | 0 | 0 | 340 | 1.431 |
| Short-term debt | 1.644 | 1.668 | 2.782 | 2.774 | 1.684 | 2.110 | 5.042 | 4.652 | 5.269 | 7.051 | 5.722 | 4.944 | 5.524 | 3.596 |
| Total debt | 6.924 | 6.292 | 6.082 | 6.074 | 4.984 | 5.410 | 5.042 | 4.652 | 5.269 | 7.051 | 5.722 | 4.944 | 5.864 | 5.026 |
EBITDA margin
34.4%
This company
15.8%
Market median
+118% vs market
20122025
Equity ratio
87.8%
This company
38.2%
Market median
+130% vs market
20122025
Return on equity
9.3%
This company
18.4%
Market median
-49% vs market
20122025
Net profit margin
28.6%
This company
8.1%
Market median
+253% vs market
20122025
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20122025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PS | Audit | 2002 | — | — |
KJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2002 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HOLDINGSELSKABET MLH ApS | Company | 50.0% | 50.0% | 2002 |
MEDI-TRADE ApS | Company | 33.3% | 33.3% | 2002 |
| Individual | 10.0% | 10.0% | 2014 | |
| Individual | 10.0% | 10.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDI-TRADE ApS
ELDON BIOLOGICALS A/S Board members of ELDON BIOLOGICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Sleimann Petersen | Audit | 0 companies |
| Kasper Juul Hedegaard | Chief Executive Officer | 0 companies |
| Michael Lützhøft Hansen | Chairman | 0 companies |
| Hans-Ole Hedegaard | Board of Directors | 0 companies |
| Hans Josef Wilms | Board of Directors | 0 companies |
| Cara Beth Seiderman | Board of Directors | 0 companies |